- Home
- MDXG
MDXG
MiMedx Group Inc
as 11-20-2024 4:00pm EST
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
| Founded: | 2006 | Country: | United States |
| Employees: | N/A | City: | MARIETTA |
| Market Cap: | 1.1B | IPO Year: | N/A |
| Target Price: | $12.00 | AVG Volume (30 days): | 1.1M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.52 | EPS Growth: | N/A |
| 52 Week Low/High: | $5.47 - $9.49 | Next Earning Date: | 10-30-2024 |
| Revenue: | $342,804,000 | Revenue Growth: | 10.93% |
| Revenue Growth (this year): | 9.56% | Revenue Growth (next year): | 9.19% |
Latest MiMedx Group Inc News
MDXG Breaking Stock News: Dive into MDXG Ticker-Specific Updates for Smart Investing
Zacks
a day ago
How Much Upside is Left in MiMedx (MDXG)? Wall Street Analysts Think 37.12%
GlobeNewswire
7 days ago
MIMEDX’s Advocacy to Rein in Runaway Medicare Spend for Skin Substitutes Has Yielded Significant Results with Planned Implementation of LCDs
Simply Wall St.
14 days ago
MiMedx Group's (NASDAQ:MDXG) Promising Earnings May Rest On Soft Foundations
Zacks
16 days ago
ChromaDex Corporation (CDXC) Hit a 52 Week High, Can the Run Continue?
Zacks
17 days ago
Can MiMedx (MDXG) Climb 77.92% to Reach the Level Wall Street Analysts Expect?
GlobeNewswire
17 days ago
MIMEDX to Participate in Upcoming Investor Conferences
Simply Wall St.
20 days ago
MiMedx Group Third Quarter 2024 Earnings: Beats Expectations
GuruFocus.com
21 days ago
MiMedx Group Inc (MDXG) Q3 2024 Earnings Call Highlights: Strong International Growth and New ...
Compare MDXG vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "MDXG MiMedx Group Inc - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.